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Abstract 
Cystic Fibrosis (CF) is an inherited disorder affecting more than 70000 people worldwide, especially 
Caucasian populations with a carrier prevalence of 1/3000. Currently, it has no cure but an early diagnosis 
remains a critical issue. Sweat chloride test has been the gold standard to diagnose CF since the affected 
present sweat chloride concentrations ≥ 60 mM. In this work, a planar electrochromic “point-of-care” device, 
based on tungsten trioxide nanoparticles produced by microwave assisted hydrothermal synthesis, was 
developed as a first approach for CF diagnostic testing especially in resource-limited environments. For 
electrodes patterning, a CO2 laser technology was used in a PET/ITO sheet. The device presents a design 
that allows the NaCl-based electrolyte deposition, used as artificial sweat, only on time of usage directly on 
the nanoparticles or in a paper pad. By applying an operating voltage of -3 V, the nanoparticles change 
their optical properties according to NaCl concentration, presenting a blue colouration with different 
intensities for different NaCl concentrations. The device was able to differentiate between a positive and 
negative diagnosis, with a colouration time of only 1 min, using an RGB analysis with a B/R ratio of 
1.37±0.03 for 60 mM of NaCl, and a low power consumption. 
Keywords: Cystic Fibrosis, sodium sweat detection, hydrothermal synthesis, electrochromic device, 
tungsten trioxide nanoparticles, colourimetric detection. 
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Resumo 
A Fibrose Quística (FQ) é um distúrbio hereditário que afeta mais de 70000 pessoas mundialmente, 
especialmente populações caucasianas com uma prevalência de portadores de 1/3000. Atualmente não 
tem cura, mas o diagnóstico precoce continua a ser uma questão crucial. O teste de cloreto no suor tem 
sido o padrão para diagnosticar a FQ, uma vez que os afetados apresentam concentrações de cloreto no 
suor ≥ 60 mM. Neste trabalho, um dispositivo point-of-care eletrocrómico planar, baseado em 
nanopartículas de trióxido de tungsténio produzidas por síntese hidrotermal assistida por microondas, foi 
desenvolvido como uma primeira abordagem para um teste de diagnóstico da FQ especialmente em 
ambientes com recursos limitados. Para a padronização dos elétrodos foi utilizada uma tecnologia de laser 
CO2 numa folha de PET/ITO. O dispositivo apresenta um design que permite a deposição do eletrólito à 
base de NaCl, usado como suor artificial, apenas no momento de utilização, diretamente nas 
nanopartículas ou num papel. Ao aplicar uma tensão operacional de -3 V, as nanopartículas alteram as 
suas propriedades óticas consoante a concentração de NaCl, apresentando uma coloração azul com 
diferentes intensidades para diferentes concentrações de NaCl. O dispositivo foi capaz de diferenciar entre 
um diagnóstico positivo e negativo, com um tempo de coloração de apenas 1 min, utilizando uma análise 
RGB com um rácio B/R de 1.37±0.03 para 60 mM de NaCl, e um baixo consumo energético. 
Palavras-chave: Fibrose Quística, deteção de sódio no suor, síntese hidrotermal, dispositivo 
eletrocrómico, nanopartículas de trióxido de tungsténio, deteção colorimétrica.  
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Motivation and Objectives 
Biosensing for medical applications allied to low-cost production procedures have shown surging 
interest over the 40 or so years. The dominant model of laboratory testing remains the centralised 
laboratory. However, due to economic pressures as well as the recognition that care needs to be more 
patient-centered, healthcare is changing. Hence, point-of-care (POC) testing has increased and this growth 
is likely to continue, delivering less costly care closer to the patient’s home. [1] 
Diagnostics are of great importance in the health care system and have a critical impact on decision 
making clinically. Compared with standard laboratory testing, POC diagnostics are facile, rapid, and 
inexpensive, and thus have great accessibility to resource-limited environments. 
Blood analysis remain the gold standard in the diagnosis of several diseases, although blood 
sampling is invasive and undesirable for most patients. Recently, eccrine sweat has emerged as an 
alternative biofluid with several sweat analysis devices, eliminating the sampling discomfort. [2] 
Cystic Fibrosis (CF) is one of multiple diseases that can be diagnosed through sweat analysis, 
measuring chloride (Cl-) concentration, and remains one of the most common life-limiting autosomal 
recessive disorders. [3] An early diagnosis of CF facilitates early implementation of therapy, which can 
significantly improve the prognosis and life quality of the affected patients. However, in Europe, the cost of 
a sweat test can vary between 20-300 €. [4]  
Numerous research groups have developed different methods for the diagnosis of CF. The trend is 
to produce a low-cost device that provides reliable results, but only few choose to implement a colourimetric 
detection by taking advantage of chromogenic materials. 
Tungsten trioxide (WO3) is a very promising material and one of the most studied electrochromic 
inorganic materials. This interest is regarding its low cost, improved stability, high colouration efficiency, 
high sensitivity, selectivity, and biocompatibility. As such, it is used in a multiple range of applications in 
environmental engineering, optoelectronics, microelectronics, selective catalysis, and even biosensing for 
medical applications. [5]–[7] 
With this in mind, the main goal of this work was the development of an electrochromic POC device, 
based on WO3 nanoparticles, for a facile diagnosis of CF especially in resource-limited environments. The 
final device cost was reduced by using alternative methods of production. 
Work strategy 
The present work was divided in three main stages: 
(i) Synthesis of WO3 nanoparticles (NPs) by hydrothermal synthesis (HS) and microwave 
assisted hydrothermal synthesis (MAHS), and respective characterizations. The NPs 
produced by MAHS went through an optimization process that consisted in the variation of 
microwave programme, synthesis’ temperature, pressure, power, and time; 
(ii) Fabrication of the device and realization of some preliminary tests to choose the best 
crystallographic structure of the WO3 NPs for the final application. Several steps related with 
the deposition of the NPs in the devices were optimized: the method used in the dispersions’ 
production, the concentration of NPs, the quantity of the dispersion for each device, and the 
drying process; 
(iii) Proof of concept with the diagnosis of CF, performing colourimetric analysis with a NaCl-
based electrolyte with different concentrations (0, 30, 45, 60, 75, 90, and 120 mM), acting as 
artificial sweat, on the devices. Furthermore, it was also studied the influence of common 
interferents in sweat, to test the selectivity of the device, and an electrochemical 
characterization was also performed. 
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Chapter I: Introduction 
1. Cystic Fibrosis 
CF, also known as mucoviscidosis, is an autosomal recessive monogenetic disorder caused by 
mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. [3], [8] Thus, in 
order to have CF a person must inherit two copies of the CFTR gene both with mutations (one copy from 
each parent). People who inherit only one defective gene are called CF carriers: they do not have the 
disease but can pass their copy on to their children. [9] 
This pathology was first identified by Dorothy Andersen, in 1938, and quickly became one of the 
most common genetic disorders, affecting more than 70000 people worldwide. Its incidence varies 
according to race and ethnicity being the Caucasian population the most affected, with a carrier prevalence 
of 1/3000. [3], [10] In Portugal, around 30-40 children are born with CF every year. [8] Currently, there’s no 
cure for it but improvements in diagnostic methods have allowed a more successful management of CF 
and led to an increased life expectancy of 40-50 years. [3] Furthermore, research on gene therapies is 
growing and it has been already developed some CF-modifying therapies like CFTR modulators. They have 
not been approved for use, though. [11] 
CF progression depends on the severity of the mutation, and so far, up to 1900 mutations in the 
CFTR gene have been described and organized into 6 classes that reflect their functional consequences. 
Class II mutations include the most common one, F508del, presenting a frequency of around 90% 
worldwide. [3], [11]  
The gene involved in this pathology, CFTR, is located in the long arm of chromosome 7 and it 
encodes for a transmembrane protein also designated CFTR (described in section A of Appendices). This 
protein acts as a Cl- channel that transports ions across the apical membrane of epithelial cells but also 
has other functions including bicarbonate secretion and inhibition of sodium (Na+) transport. As a member 
of the Adenosine triphosphate (ATP)-binding cassette (ABC) transporter family, this protein uses energy 
released by ATP hydrolysis to move substrates (ions in this case) against their electrochemical gradient. 
Multiple studies reported that CFTR also regulates the activity of the epithelial sodium channel (ENaC). 
Therefore, CFTR dysfunction restricts the reabsorption of Cl- (and subsequently Na+) in the reabsorptive 
duct of the sweat gland, a process that normally occurs in healthy individuals, as well as the transport of 
bicarbonate. As a result, in addition to a high NaCl concentration in sweat being an effective evidence of 
CF, this dysfunction leads to the production of an abnormal viscous secretion in several organs. [11]–[13] 
This mucus particularly blocks the lungs and causes persistent lung infections due to germs’ multiplication, 
being lung disease responsible for the majority of mortality. [9] However, its phenotype extends to multiple 
organs. In the pancreas, mucus prevents the release of digestive enzymes that later results in pancreatic 
insufficiency, gastrointestinal malabsorption, intestinal abnormalities, malnutrition and poor growth. It can 
also cause liver disease, diabetes, azoospermia in 98% of the affected males, renal complications, salt and 
water depletion, among others. [3], [10]  
1.1. CF diagnostic 
A complete diagnostic evaluation for CF includes a sweat test (in support of the newborn bloodspot 
screening (NBS)), a genetic test, and a clinical evaluation. [10] It is noteworthy that in Portugal, since 2013, 
CF is included in the so-called “teste do pezinho”, an early diagnostic test for several diseases. [14] 
For 60 years, sweat tests have been the gold-standard to diagnose CF and the most employed one 
is the quantitative pilocarpine iontophoresis testing (QPIT), which consists in the determination of Cl- 
concentration in sweat. It was originally introduced in 1959 by Gibson and Cooke, and nowadays is 
implemented by following the Clinical and Laboratory Standards Institute (CLSI) 2009 Guidelines. [12] 
Perspiration is locally induced on the forearm skin through the administration of pilocarpine nitrate and then, 
an electric current is applied to stimulate the sweat glands. Sweat is usually collected on a gauze or filter 
paper (both requiring about 75 mg of sweat), and more recently in a Macroduct® coil (15 µL) for 30 min, 
and a minimum sweat rate of 1 g/m2/min is required. Then, Cl- levels are generally measured using 
coulometry (chloridometer). [15]–[17] Concentrations below 30 mmol/L are considered negative for CF and 
positive above 60 mmol/L. However, there is a range of inaccurate diagnosis for concentrations between 
30 and 60 mmol/L and patients within this range are classified as indeterminate cases, requiring further 
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evaluation. To confirm the veracity of these values, in 2014, Rowe et al. evaluated sweat Cl- levels as a 
function of predicted CFTR activity and concluded that healthy adults had a mean sweat Cl- concentration 
of 20 mmol/L, CF carriers presented mean levels of 26 mmol/L, CF patients with one severe and one mild 
CFTR mutation had an average of 80 mmol/L, and patients with two severe mutations had an average in 
excess of 100 mmol/L. [11], [18] 
For indeterminate cases and also to standardize CF diagnosis worldwide, CFF developed a diagram 
of diagnostic steps presented in Figure 1. [13], [18]–[21]  
 
Figure 1: Diagram developed by CFF to standardize the correct way to diagnose CF. [21] 
The tests may not be done in this order, but hierarchically to establish the diagnosis of CF, sweat 
test should be done first, then CFTR genetic analysis, and finally CFTR physiologic tests. The final result 
of CFTR genetic analysis may be a known mutation of varying clinical consequence (MVCC). This means 
that combined with a CF-causing mutation or another MVCC, the mutation may result in CF. For that 
reason, a nasal potential difference (NPD) test or an intestinal current measurement (ICM) test is needed 
to reach or not the CF diagnosis. [21] 
Besides the intermediate range uncertainty and the amount of sweat required, the Gibson and Cooke 
QPIT also requires experienced staff and procedures like sweat collection are liable of failure, leading to a 
high frequency of technical errors. So, the development of new, low-cost, POC and portable devices for CF 
diagnosis is of great importance. [12] Gonzalo-Ruiz et al. developed a disposable screen-printed sensor 
device to induce sweat and measure the Cl- concentration by potentiometry for CF detection. [22] 
Schazmann et al. described a Na+ sensor belt based on a Na+ Ion Selective Electrode (ISE). [23] Wang et 
al. developed a device for Cl- concentration detection using the fluorescence intensity of a Cl- ion fluorescent 
indicator. [24] Bandodkar et al. showed an epidermal temporary-transfer tattoo-based potentiometric sensor 
coupled to a wireless transceiver for real-time monitoring of Na+, but no specific disease is addressed. [25] 
In 2014, Rock et al. reported a method for quantitative sweat Cl- determination, the CF Quantum® sweat 
test, which uses an ion exchange reaction between sweat Cl- anions and silver chromate. It is not a POC 
device though. [26] Mu et al. developed a colourimetric paper-based device for CF screening, directly on 
skin, combining both anion exchange and pH test papers. However it is not selective. [27] In 2016, Gao et 
al. reported a wearable Bluetooth-enabled band containing a panel of sensors for sweat electrolytes 
including Na+, which is measured through the use of ISEs. [28] De Matteis et al. showed a POC 
electrochromic device capable to diagnose CF, with high selectivity for Na+, using the well-known WO3. [12] 
Emaminejad et al. developed a fully integrated wearable platform to stimulate sweat and measure sweat 
electrolytes like Na+ and Cl-, reporting its use for CF diagnosis. [29] Recently, microfluidic devices for sweat 
electrolyte quantification by colourimetric detection, potentiometry or ISEs have been vigorously developed. 
Anastasova et al., Matzeu et al., Choi et al., and especially John A. Rogers’ research group are some 
examples. [30]–[35] 
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2. Electrochromism: fundamentals and applications 
As mentioned before, colourimetric detection has been widely explored and represents an attractive 
way for a rapid detection of multiple analytes. Chromogenic materials are often explored concerning this 
topic, as they are capable of undergoing controlled reversible changes in their optical response 
(transmission, absorption, and reflection), generated by an external stimulus which promotes a modification 
in the material’s chemical or physical state. When the external stimulus is an electrical current or potential, 
the phenomenon is called electrochromism. [36] This property makes them appealing for several 
applications like electrically switchable rear-view car mirrors for anti-dazzle, reusable price labels, glazing 
units for temperature and light control, smart windows, and visual displays, to name just a few. [37], [38] 
According to Granqvist, a high impact scientist in this specific area, electrochromism is the reversible 
and persistent change of the optical properties of a material, when an electrical potential is applied to it. 
[39] The optical absorption of the material is modified through the insertion of both electrons and charge-
balancing ions. As such, the principle is based on a redox reaction, and once it is a reversible process, the 
material has the ability to switch between two distinct oxidation states: the coloured and the bleached state. 
The colour change is commonly between a transparent and a coloured state, or between two coloured 
states. [40], [41] 
Electrochromic materials embrace both organic and inorganic materials. [42] However, inorganic 
electrochromic materials have been widely reported in the literature owing to their photochemical stability 
whereas the organic alternatives may be susceptible to photochemical degradation. [43] Among this group, 
transition metal oxides stand out, especially WO3 which is described in section 2.1., as they exhibit both 
cathodic and anodic colouration phenomenon: colouration under ion insertion (oxidized coloured state) and 
under ion extraction (reduced coloured state), respectively. [42] Oxides based on vanadium present 
intermediate electrochromic properties as they are capable of both colouration types. On the contrary, 
oxides based on tungsten and iridium only undergo cathodic and anodic colouration, respectively. In fact, 
most electrochromic devices based on oxides employ two electrochromic films, taking advantage of 
combining cathodic and anodic oxides (WO3 and Ni(OH)2 for example). This way, when applying a voltage 
to transport ions and electrons in one direction, both oxides colour, and when transporting ions and 
electrons in the other direction, both oxides bleach. Consequently, a more efficient device is obtained. [38] 
There are multiple configurations for electrochromic devices, depending on property requirements. 
A typical electrochromic device schematic is depicted in Figure 2 with four layers between two transparent 
substrates that are usually from transparent glass or a flexible polyester (polyethylene terephthalate (PET), 
for example). The substrates are then coated with a transparent conductive oxide (TCO) like indium tin 
oxide (ITO), being one of them coated with an electrochromic material and the other with an ion storage 
film, which is not represented in the schematic but was already mentioned as part of most devices. The 
electrolyte, a pure ionic conductor, separates them. [42], [44] 
 
Figure 2: Schematic of a typical electrochromic device. Adapted from [45]. 
When a voltage is applied between the TCOs, a distributed electrical field is set up on the device and 
the ions from the electrolyte move uniformly into and out of the electrochromic material. The charge-
balancing counterflow of electrons then leads to an electron density’s variation in the electrochromic 
material, leading to a modulation of its optical properties. After the decay of the resulting pulse of current, 
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if the ion conductor has negligible electronic conductivity, the device will exhibit an open circuit memory 
(the so-called “memory effect”), and the optical properties remain stable for long periods of time. [41], [44]  
The appropriate selection of the electrolyte is one of the key parameters for electrochemical 
processes, and they may be solid, liquid or elastomeric. Concerning the liquid electrolytes, fluids of high 
viscosity are usually preferred, for convenience and safety. [40] 
Polyethylene oxide (PEO) based electrolytes are among the most studied because of their beneficial 
structure in supporting fast ion transport. High conductivity seems to be related with the facile dissolution 
of the cation by the coordination group of the polymer that, in this case, is an ether oxygen. PEO is a semi-
crystalline linear polymer, presenting both amorphous and crystalline phases at room temperature. Its 
chemical structure has series of –O– polar groups which can easily associate with metal cations (Figure 30 
b) from section D of Appendices). However, PEO itself presents an extremely low reactivity. [46], [47]  
A high crystalline phase concentration limits the conductivity of PEO based electrolytes. One of the 
most successful approaches to suppress it is the preparation of polymer blends between PEO and an 
acrylic polymer. Polyvinylpyrrolidone (PVP) is often chosen as it presents an amorphous nature allowing 
faster ionic mobility (Figure 30 b) from section D of Appendices). Besides, the rigid pyrrolidone group of 
PVP is known to form various complexes with several inorganic salts. Sodium complexed electrolyte films 
have been found to exhibit multiple advantages. In fact, the mobility of bigger ions like Na+ is higher than 
that of smaller ions (lithium – Li+ – and magnesium – Mg2+) in the polymer electrolytes once smaller cations 
are captured by the polymeric network. [46], [47] 
As solvents, common organic ones are normally undesirable due to their inherent toxicity and high 
flammability. However, propylene glycol (PG) is an example of an organic solvent with low flammability and 
one of the least toxic of the glycols. [48] Furthermore, it is one of the best solvents for NaCl since the salt 
presents a solubility of 71 g/kg (at 25 ºC) for this solvent. [49] 
Many electrochromic devices comprise a sandwich structure of thin layers, including one for the 
electrolyte. When using liquid electrolytes, there’s a higher probability to deal with risks of leakage, long-
term sealing problems and, therefore, a short shelf life of the device. However, their ionic conductivities are 
higher. [39], [42], [44], [45] As such, to overcome the mentioned drawbacks, an electrochromic device with 
a planar structure and two electrodes defined as working and counter electrode (WE and CE, respectively) 
can be a solution, being the WE named this way once the redox reactions occur on the NPs deposited on 
top of it. [50] The device is produced without any electrolyte, and its deposition, by drop-casting on both 
electrodes, is only performed on time of usage. Therefore, instead of using an electrolyte layer typical of a 
stacked multilayer structure, it is used a hydrophilic paper encapsulated inside the device, covering both 
electrodes. The layout of the device is shown in Figure 4 from the next Chapter, and as can be seen, its 
planar structure, besides the already mentioned advantages, represents a totally innovative way to produce 
electrochromic devices, since most part of them comprise the conventional sandwich structure of layers. 
2.1. Tungsten trioxide 
As already mentioned, WO3 remains one of the most studied and used electrochromic inorganic 
materials due to some of its properties like improved stability, high colouration efficiency, high sensitivity, 
selectivity, and biocompatibility. In addition to its application as an electrochromic material, WO3 can also 
be used in pH and gas sensors, photocatalysis, solar energy devices, biosensors, among others. [5]–[7], 
[51] The electrochromism in this material is based on the following redox reaction [41]: 
WO3 (transparent) + xM
+
+ xe- → MxWO3 (blue)                                              (1) 
where M+ is a cation of the alkali metal group (H+, Li+, Na+ or K+), e- represents an electron and x, the 
insertion coefficient, indicates the fraction of electro-reduced tungsten sites. As such, when WO3 integrates 
electrons and ions, to maintain its electro-neutrality, it can be reversibly transformed into a tungsten bronze 
(MXWO3), with total different properties and which presents a blue colouration. [39], [41], [43]  
The crystal structure of WO3 allows the intercalation of ions, once it presents a considerable 
interstitial space for the process to occur. WO3 is formed by a sequence of perovskite-like (WO6) octahedral 
building blocks with connecting corners in three dimensions, which can be visualized as an infinite 
framework of corner-sharing WO6 octahedra, each with a central tungsten ion (W6+) surrounded by six 
equidistant oxygen ions. An ideal WO3 crystal structure can be considered as a rhenium trioxide (ReO3) 
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type cubic structure, as depicted in Figure 3. [42], [52] However, the WO6 units undergo tilting, rotation, or 
displacement of the central W atoms, promoting several crystalline modifications to WO3. As such, 
symmetries like hexagonal, cubic, tetragonal, orthorhombic, monoclinic or triclinic, are found, being the last 
four reversibly transformed into each other by changing the temperature. [53], [54] Among these 
symmetries, the hexagonal one outstands due to its hexagonal tunnels, that are particularly relevant to the 
chromogenic behaviour, once the spaces between the WO6 octahedra are large enough to accommodate 
ions. [42], [55] In section B of Appendices, a brief description of the monoclinic, orthorhombic and hexagonal 
structures is presented. 
 
Figure 3: Crystal structure of WO3: (a) the ideal cubic structure; and (b) the WO6 octahedra. [54] 
So far, multiple methods have been reported to synthesize nanostructured tungsten oxides with 
various morphologies: sputtering, temperature annealing, hot wire chemical vapor deposition, pulsed laser 
irradiation, sol-gel, electrodeposition, precipitation, anodization, and also hydrothermal methods. [5], [56] 
Among these methods, hydrothermal method is a facile, dominant tool for the synthesis of anisotropic 
nanoscale materials. [57] 
2.1.1. Hydrothermal synthesis 
HS is a low-cost method extremely used in the crystallization of substances from high-temperature 
aqueous solutions (usually below 300 ºC) at high vapor pressures, allowing an improved solute dissolution. 
[58] The crystal growth is performed in a steel pressure vessel (autoclave), in which a reagent is supplied 
along with water as solvent (precursor solution). The autoclave is then placed in an oven and a gradient of 
temperature is maintained at its opposite ends. This way, the hotter end dissolves the reagent and the 
cooler end causes seeds to take additional growth. [59] 
This method presents significant advantages regarding the better control over the crystal growth, 
shape, and size, low synthesis temperature, cost-effectiveness, low number of impurities, improved product 
yield, and good homogeneity of the nanoparticles synthesized. [5], [51], [57] However, with the reduction 
of synthesis’ temperature, the reaction’s kinetic becomes slower. To overcome this issue, hydrothermal 
hybrid techniques have been developed, being MAHS one of the most popular. Heating in the conventional 
method is considered inefficient since it depends on the convection currents, and on the thermal 
conductivity of the materials that must be penetrated, resulting in a discrepant temperature between the 
autoclave, that has a higher temperature, and the reaction mixture. On the contrary, a material processed 
in a microwave interacts with the electromagnetic radiation and not with the radiant energy. As the heat is 
generated by the material itself, being a result of the interaction between the electromagnetic wave and the 
electric dipole of the mixture’s molecules, the temperature of the whole volume is simultaneously raised in 
a faster and uniform way. [59]–[61] As such, MAHS is a greener approach than HS, once it reduces energy 
costs.  
Concerning the synthesis of WO3 NPs by HS methods, the use of structure-directing agents (SDAs) 
to direct and control the crystal growth during synthesis is very common. Multiple SDAs were reported in 
literature: Na2SO4, (NH4)2SO4, Li2SO4, and NaCl are some examples. It is believed that capping agents 
containing sulphate ions dictate an anisotropic one-dimensional growth by selectively binding to specific 
facets of the initial crystal nuclei of WO3. Their adsorption decreases the surface energy of the WO3 seed 
crystals in all directions, inhibiting growth rates, except one, which allows the obtention of one-dimensional 
wire/rod-like structures. [57], [62]  
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Chapter II: Experimental Methods 
It is noteworthy that the information of all used materials is presented in section C of Appendices. 
1. WO3 NPs production 
WO3 NPs were produced via HS and MAHS. For HS, and based on Santos et al. work [6], 0.4 g of 
Na2WO4∙2H2O were dissolved in 8 mL of deionized H2O and then acidified with 0.83 mL of HCl 3 M. 
Reagents were mixed for 1 h at 500 rpm while sealed. The mixture was then transferred to a Teflon cup, 
set inside a stainless-steel autoclave and placed in a L3/11/B170 Nabertherm oven for 1 h at 180 ºC, with 
a heating ramp of 30 min. For MAHS, and based on Marques et al. work [51], WO3 NPs with three different 
crystallographic structures were produced, as illustrated in Table 1. 
Table 1: Reagents and quantities used for WO3 NPs synthesis via MAHS, based on Marques et al. work. [51] 
Na2WO4∙2H2O 
(g) 
NaCl (g) H2O (mL) 
HCl 3 M 
(mL) 
pH 
Crystallographic 
structure 
Nomenclature 
0.8 
0.36 
2 13.33 0.0 Monoclinic WN1 
16 1.67 1.8 Orthorhombic WN2 
Na2SO4 (g)      
0.72 16 1.67 1.8 Hexagonal WN3 
For each sample, after adding H2O to the solid reagents, there was a stirring step of 6 min, and after 
HCl addition a stirring step of 20 min, both at 500 rpm, and always sealing the recipients. The mixtures 
were then transferred into a 35 mL microwave vessel, sealed, and heated in a microwave reactor Discover 
SP from CEM Corporation. All synthesis went through an optimization process varying the microwave 
programme, temperature, pressure, power, and synthesis’ time. After synthesis, the nanopowders obtained 
were collected by centrifugation at 4000 rpm during 10 min, using a F140 Focus Instruments centrifuge, 
followed by a washing process with deionized water during a centrifugation of 5 min, and then 2 min. The 
collecting and washing process was also applied to the HS sample. 
Two methods were studied to produce the WO3 NPs dispersions from HS and MAHS. The first 
method consisted in drying the final powders, after the washing process, using a “Vacuo-Temp” desiccator 
(J. P. Selecta) for 10 h at 70 ºC, under vacuum. Then, the solids obtained were grounded, using a mortar 
and pestle to obtain fine powders, and dispersed in a 1:1 mixture of ethylene glycol butyl ether (EGBE) and 
deionized water. The second method consisted in dispersing the powders, right after the washing process, 
using the same mixture described for the first method. All dispersions were stored in glass flasks, sealed, 
and protected from light with aluminium foil. The ideal concentration was also studied and optimized. 
2. Devices’ production 
In Figure 4, it is presented an illustration of a single device layout as well as its dimensions and its 
main production steps.  
  
a) b) 
Figure 4: a) Layout of the final device and its dimensions with a= 0.1 cm and b= 0.07 cm. b) Schematic 
representation of the device production: 1. ITO layer etching; 2. WO3 NPs deposition; 3. Hydrophilic paper 
encapsulation. Adapted from [50]. 
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The first production step (Figure 4 b) 1.) was the definition of the electrodes and the electrical tracks 
of the device. This was achieved by making a negative pattern of them in a PET/ITO sheet by laser etching 
the ITO layer. The equipment used was a computer-controlled CO2 Infrared laser-cutting machine VLS 3.50 
(Universal LASER systems) with a 10.6 µm wavelength, at 10 W, 1.27 m/s and 1000 PPI (pulses per inch). 
Then, the patterned sheet went through a 3-step cleaning process: first, with detergent; second, with an 
ultrasonic bath, using a Sonorex Super RK 514/H (Bandelin), for 10 min with deionized water; and third, 
also with an ultrasonic bath for 10 min with ethanol. The sheet was finally dried with nitrogen jet. 
The second production step (Figure 4 b) 2.) involved the electrical contacts painting with Silver (Ag) 
conductive ink and the deposition of WO3 NPs. To simplify this step, the layout of the contacts was cutted 
into a self-adhesive film, also using the laser-cutting machine at 40 W, 1.016 m/s and 1000 PPI. The film 
was sticked to the patterned PET/ITO sheet, and the ink was deposited with a brush. The sheet with the 
devices was then processed on a hot plate (120 °C, 10 min), with no contact with it, for ink curing. After 
cooling down, the self-adhesive film was removed, and the deposition of WO3 NPs dispersion was carried 
out by drop-casting of 2 µL (while stirring) onto the WE, followed by a drying process at room temperature 
overnight, protected from the light. 
The final step (Figure 4 b) 3.) comprised the encapsulation of a hydrophilic paper pad within the 
device. Using the laser-cutting machine at 40 W, 1.016 m/s and 1000 PPI, Whatman paper grade n.º4 was 
cutted into the pattern represented in Figure 4 b) 3.. Lastly, all the devices were encapsulated on plastic 
laminating pouches using a Mars A4 Laminator (Fellowes), with the hydrophilic papers inside, covering the 
area of the WE and CE. This only happened after laser patterning the pouches at 3 W, 0.0762 m/s and 
1000 PPI, with delimiting lines for a single device, and cutting a square to allow access to the electrical 
tracks. For the consequent electrolyte impregnation, a small pad was left outside of each device. The final 
devices were individualized to a dimension of around 1.4 x 2.0 cm. 
It is noteworthy that the vector image software Adobe illustrator (Adobe systems software) was used 
to draw all the layouts employed during this experimental work.  
3. WO3 NPs characterization 
The structural characterization of the different WO3 NPs was performed by X-ray diffraction (XRD) 
using a PANalyticalX’Pert Pro X-ray diffractometer in Bragg–Brentano geometry, with a monochromatic 
Cu-Kα radiation source (wavelength 1.5406 Å). All measurements were carried out from 10 to 70º (2θ).  
As a supplement for structural analysis, it was used a Renishaw inVia Qontor confocal Raman 
Microscope using a 633 nm laser (1% power) and a Leica N PLAN L50x/0.50 BD Microscope objective. 
The time of exposure was 10 s, and spectra was obtained after 3 accumulations.  
Finally, the morphology of the WO3 NPs was analysed by scanning electron microscopy (SEM) using 
a Carl Zeiss AURIGA Crossbeam (SEM-FIB) workstation instrument. 
4. Devices’ characterization 
To examine the effectiveness of the ITO etching, it was performed an Energy Dispersive X-Ray 
Spectroscopy (EDS) on a device, with an Oxford INCA x-act coupled to the SEM workstation. Then, to 
optimize some parameters of production, preliminary tests were carried out before the encapsulation step 
using a LiClO4:PC 1 M electrolyte. The electrolyte was drop-casted right on top of the WE and CE, and a 
DC Power Supply PS-303D-II from ZHAOXIN Electronics Co., Ltd was used at -3 V for 30 min, to assess 
colour modulation. 
For the final characterizations, an electrolyte based on PEO, PVP, PG, and different concentrations 
of NaCl (0, 30, 45, 60, 75, 90, and 120 mM), to simulate the human sweat, was produced (section D of 
Appendices) and drop-casted as mentioned above on the devices (before and after encapsulation). Then, 
it was performed a colourimetric analysis at -3 V for different times, using the aforementioned power supply. 
The results were recorded with an Apple Iphone X, and colour development analysis was performed with 
ImageJ software (National Institutes of Health) through a Red Green Blue (RGB) control. It was also studied 
the influence of common interferents in sweat, using KCl and MgO4S in the production of other electrolytes 
(section D of Appendices). For electrochemical characterization, it was used a Gamry 600 Potentiostat from 
Gamry Instruments, and chronocoulometry and cyclic voltammetry measurements were performed to fully 
characterize the devices.  
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Chapter III: Results and Discussion 
In this chapter, the results obtained throughout this work are presented and discussed.  
Firstly, it is presented the WO3 NPs synthesis optimization process by MAHS as well as the structural, 
morphological and chemical characterization of the NPs obtained. The ones obtained by HS are also 
presented and characterized. Then, the devices production and the results of some preliminary tests 
realized to optimize the devices are presented and discussed. The chapter ends with the devices’ final 
characterizations: colourimetric study, electrochemical characterization, and some selectivity tests. 
1. WO3 NPs synthesis and characterization 
The first step of this work was the optimization of WO3 NPs production by MAHS, in order to obtain 
three crystallographic structures: monoclinic, m-WO3 (WN1); hydrated orthorhombic, o-WO3∙0.33H2O 
(WN2); and hexagonal, h-WO3 (WN3). To achieve these structures, certain parameters were studied: the 
microwave programme, temperature, pressure, power, and synthesis’ time.  
The first programme tested was “Fixed Power”. Basically, the synthesis occur at a constant power of 
100 W for 1 h (maximum) and with a maximum safe temperature of 200 ºC, conditions already studied by 
Marques et al.. [51] A different programme was also tested, “Dynamic”, which consisted in a constant 
temperature of 160 ºC, and a dynamic power (200 W maximum) in order to maintain the temperature. The 
maximum pressure was 300 psi and the programmed synthesis’ duration was 40 min. Finally, the last 
modifications to the programme were the increase of temperature to 180 ºC and duration to 1 h, and the 
decrease of maximum pressure to 280 psi. A resume of all conditions tested in the MAHS optimization 
process is presented in Table 2. 
Table 2: Conditions tested during the MAHS optimization process. 
 
Microwave programmes 
Fixed Power Dynamic Dynamic 
Power (W) 100 (constant) 200 (max.) 
Temperature (ºC) 200 (safe) 160 (constant) 180 (constant) 
Time (min) 60 40 60 
Pressure (psi) 300 (max.) 280 (max.) 
In addition to MAHS, HS was also used to produce WO3 NPs with o-WO3∙0.33H2O crystallographic 
structure. Although it did not undergo through an optimization process, this synthesis was later tested on 
the devices along with the ones produced by MAHS with the best conditions. 
1.1. MAHS optimization process 
During the preparation of the solutions to undergo MAHS, it was possible to notice the precipitation 
of a white solid right after the addition of HCl (Figure 5 a)). This solid corresponds to tungstic acid, an 
intermediate product, and its formation was more perceptible in WN1 once this sample presented the lowest 
pH. For samples WN2 and WN3, the addition of HCl only formed kind of a white mist in the respective 
mixture. 
The formation of this acid is the first of three major steps of WO3 NPs production. The tungstic acid 
(H2WO4∙nH2O) is produced when the precursor solution is acidified, reason why pH plays such an important 
role in the formation of WO3 (Eq. 2). Then, as this product is decomposed, the formation of WO3 aggregates 
takes place, as described in Eq. 3, leading to the WO3 NPs grow. All synthesis were produced with a pH 
bellow 2, because for higher values the formation of the acid does not occur. [62]–[64]  
WO4
2- + 2H+ + nH2O → H2WO4∙nH2O                                                     (2) 
H2WO4∙nH2O → WO3 + (n+1)H2O                                                        (3) 
Figure 5 b), c), and d) represent the final result of the synthesis using the “Fixed Power” programme 
at 100 W during 1 h for each sample. 
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a) b) c) d) 
Figure 5: Observations from the synthesis of WO3 NPs by MAHS. a) Precipitation of tungstic acid after the 
addition of HCl in WN1 sample. b) WN1, c) WN2, and d) WN3 samples obtained using the “Fixed Power” 
programme at 100 W. 
All three samples did not achieve a synthesis’ time of 1 h. The maximum time was obtained for WN3 
sample and the minimum for WN1. 
The difference between the yield of the three samples is remarkable. WN1 and WN2 presented close 
yields and higher than the one of WN3, which was very low. This fact can be associated with the synthesis’ 
conditions, once the maximum synthesis’ time of WN3 sample was 15 min. Probably, this time was not 
enough to allow the total reaction between reagents. Besides this difference, there was also a difference 
between the colours obtained. WN1 sample presented a yellow colouration, characteristic of the monoclinic 
crystallographic structure, while WN2 and WN3 presented a white one.  
To analyse the crystallographic structures obtained for each sample, XRD analysis were performed 
and are presented in Figure 6. 
 
Figure 6: Diffractograms of the three WO3 NPs samples produced by MAHS, using the “Fixed Power” 
programme at 100 W. Peaks marked with ◊ and ♦ are characteristic of H2WO4∙nH2O and m-WO3 crystallographic 
structures, respectively. 
The crystallographic structures of the samples were identified by comparing the results obtained with 
the crystallographic files deposited in the International Centre for Diffraction Data (ICDD) data base with 
the references #98-007-1506, #98-003-7822, and #98-001-3851 for monoclinic, hydrated orthorhombic, 
and hexagonal crystallographic structures of WO3, respectively, and #98-004-6169 for tungstic acid. To 
accomplish that, it was used the HighscorePlus PANalytical software.  
Analysing Figure 6, it is possible to conclude that WN1 did not achieve the m-WO3 crystallographic 
structure. Its diffractogram presents only two typical peaks of m-WO3 (♦: 33.37º and 55.9º) while the others 
are characteristic of H2WO4∙nH2O (◊), the intermediate product. Basically, the experimental conditions did 
not allow the total decomposition of H2WO4∙nH2O once WN1 synthesis had a maximum duration of around 
8 min and a temperature of only 100 ºC. For WN2 sample, all peaks were identified as characteristic of o-
WO3∙0.33H2O. However, comparing with the respective crystallographic file, some peaks are absent in the 
diffractogram obtained, which means the o-WO3∙0.33H2O crystallographic structure was not fully reached. 
Finally, the diffractogram of sample WN3 presents few perceptible peaks once the synthesis’ conditions 
were not suitable and its yield was very low. However, the peaks that could be identified are characteristic 
of h-WO3 crystallographic structure. 
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As the conditions of this programme were not suitable to obtain the desired crystallographic 
structures of WO3, another programme was tested: “Dynamic”. This programme allows a better control of 
the temperature during the synthesis as well as the time. Furthermore, with these modifications it was 
expected a greater yield for WN3 sample. Among tungsten trioxides, h-WO3 is of particular interest once it 
is better suited for the transport of ions, which justifies the interest in the improvement of the WN3 sample. 
This feature is due to its open-tunnel structure that can act as an intercalation host for cations and electrons 
to form tungsten bronzes MxWO3. [65] 
The powders obtained using the “Dynamic” programme at different temperatures and times, are 
presented in Figure 7. 
Dynamic 160 ºC Dynamic 180 ºC 
 
a) 
 
b) 
 
c) 
 
d) 
 
e) 
 
f) 
Figure 7: Powders obtained using the “Dynamic” programme at 160 ºC during 40 min for a) WN1, b) WN2, and 
c) WN3; and at 180 ºC during 1 h for d) WN1, e) WN2, and f) WN3. The vessels here presented have a maximum 
volume of 10 mL. 
For the “Dynamic” programmes, all samples reached the time and temperature defined in the 
beginning of the synthesis. The sample with the highest yield at 160 ºC was WN2, and WN1 at 180 ºC. 
However, for each condition, the yields were very close for these two samples. The difference is that in 
Figure 7 b) the WN2 powder was not so compact as the one from WN1 (Figure 7 a)). Comparing the powder 
obtained for WN3 sample using this programme with the obtained using the aforementioned, it is noticeable 
an improvement, as desired. The aspect of the powders is equal to the aspect of the previous ones, with a 
slight difference related to the colour of WN1, which in Figure 5 b) was a strong yellow (“Fixed Power” 100 
W) and became a pale yellow in “Dynamic” programme at 180 ºC. To understand if this colour change is 
related with some modifications in the crystallographic structure of the sample, XRD analysis was 
performed, as well as for the other two samples. The results are presented in Figure 8. 
Dynamic 
a) 160 ºC for 40 min b) 180 ºC for 1 h 
  
Figure 8: Diffractograms of the three WO3 NPs samples produced by MAHS using the: a) “Dynamic” 
programme at 160 ºC for 40 min; and d) “Dynamic” programme at 180 ºC for 1 h. Peaks marked with ◊ are 
characteristic of H2WO4∙nH2O crystallographic structure. 
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Analysing the diffractograms, it is possible to note some changes during the optimization process for 
each sample. The variation of the previously mentioned factors led to the achievement of the expected 
WO3 crystallographic structures as well as their improvement: m-WO3 (WN1), o-WO3∙0.33H2O (WN2); and 
h-WO3 (WN3). This supports the use of the “Dynamic” programme over the “Fixed Power” at 100 W. 
All samples were produced using Na2WO4·2H2O as a precursor, and NaCl (WN1 and WN2) or 
Na2SO4 (WN3) as a SDA. It is remarkable the influence of the sample’s pH in the crystallographic structure 
obtained, factor already studied by Marques et al. and previously mentioned. [51] The pH was the only 
difference between WN1 and WN2 (0.0 and 1.8, respectively) but it was enough to obtain different WO3 
crystallographic structures (m-WO3 and o-WO3∙0.33H2O, respectively). Using Na2SO4 as SDA with a pH of 
1.8, the WO3 NPs grew with an h-WO3 crystallographic structure. 
In Figure 8 a), the diffractograms of the three samples produced using the “Dynamic” programme at 
160 ºC for 40 min are presented. For WN1, and comparing with the previous results, the improvement is 
noticeable since it was achieved the crystallographic structure of m-WO3 (♦) with only three peaks that 
correspond to H2WO4∙nH2O (◊: 16.56º, 25.7º, and 35.07º). In the diffractogram of WN2, it starts to appear 
a characteristic peak of o-WO3∙0.33H2O crystallographic structure at around 18.08º, that was absent in the 
previous diffractogram (Figure 6). However, for WN3 these conditions are still not enough to reach the 
desired crystallographic structure of h-WO3. 
As already mentioned, the temperature and duration of the “Dynamic” programme were changed for 
180 ºC and 1 h, respectively, and the diffractograms obtained are in Figure 8 b). All peaks of WN1 
diffractogram correspond to the crystallographic structure of m-WO3 which means these conditions allowed 
the total decomposition of H2WO4∙nH2O. It is now possible to realize that the differences in the colour of 
this sample throughout the optimization process are related to the changes in its crystallographic structure. 
The strong yellow is characteristic of H2WO4∙nH2O while the paler yellow is characteristic of m-WO3. For 
WN2, all peaks are typical of o-WO3∙0.33H2O, and for WN3, the improvement is clear compared to the 
diffractograms of Figure 6 and Figure 8 a). WN3 peaks are all characteristic of h-WO3. 
In order to facilitate the perception of the optimization process for each sample (WN1, WN2, and 
WN3), all XRD analysis data presented is differently arranged in Figure 31 in section E of Appendices.  
 SEM analysis 
The surface morphology of the samples produced via MAHS was analysed by SEM, and is presented 
in Figure 9. For the same precursor (Na2WO4∙2H2O) three different morphologies were obtained: 
rectangular nanoplates assigned to m-WO3 (WN1), nanosheets assigned to o-WO3∙0.33H2O (WN2), and 
nanowires assigned to h-WO3 (WN3). 
According to XRD analysis, WN1 sample went through some changes in its crystallographic structure 
from H2WO4∙nH2O to m-WO3 (“Fixed Power” at 100 W to “Dynamic” at 180 ºC for 1 h). This is confirmed by 
Figure 9. With the increment of synthesis’ temperature and time, the irregular nanoplates gradually 
transformed into completely rectangular nanoplates with sharp corners and smooth surfaces. Several 
clusters can also be seen. This increment also promoted the growth of WN3 sample nanowires, both in 
length and width, probably due to a slower nucleation. [64] It is also noticeable the formation of some 
clusters. Finally, for WN2 sample, there was also a morphological uniformization of the nanosheets 
throughout the MAHS optimization process. 
It is also clear the influence of the SDAs (NaCl – WN1 and WN2, and Na2SO4 – WN3) in the 
morphology of the WO3 NPs obtained, when the same precursor is used. The sulphate ions acted as 
capping agents by selectively binding to some crystal facets of the initial WO3 crystal nuclei, covering them. 
For WN3, at pH 1.8, it is observed a faster growth rate along c-axis, leading to the formation of one-
dimensional wire-like structures. Furthermore, a certain amount of sodium cations is required to stabilize 
the hexagonal and triangular tunnels in the formation of h-WO3 in the sample. When chloride ions are used, 
instead of sulphate, it is believed that a similar process occurs, being the growth of the initial WO3 crystal 
nuclei favoured in a specific direction. [51], [62] Compared to the other two morphologies, the 
unidimensional structure of h-WO3 confers new and optimized characteristics to the material in terms of 
superficial area and physical properties like optical, magnetic and electronic ones. 
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Figure 9: SEM images of the three different samples (WN1, WN2, and WN3) produced using the “Fixed Power” 
programme at 100 W, and using the “Dynamic” programme at 180 ºC for 1 h. 
The dimensions of the NPs obtained were also determined, using the software ImageJ. The results, 
concerning the length of the NPs, are presented in Table 3. 
Table 3: Dimensions obtained for the WO3 NPs produced by MAHS with the programmes “Fixed Power” at 100 
W and “Dynamic” at 180 ºC for 1 h, using the software ImageJ (n=40).  
 
NPs length (nm) 
Fixed Power 100 W Dynamic 180 ºC 1 h 
WN1 116 ± 44.3 107 ± 47.7 
WN2 914 ± 270 826 ± 258 
WN3 171 ± 41.6 350 ± 122 
 Raman spectroscopy 
In order to complement the analysis performed, the crystal structure of the final three optimized WO3 
NPs samples produced by MAHS (WN1, WN2, and WN3) was also characterized by Raman spectroscopy. 
The normalized spectrum of each sample is presented in Figure 10. 
The well-resolved peaks in the spectra indicates that all samples are crystalline. Crystalline WO3 has 
three main spectral regions: one between 900 and 600 cm-1, other between 400 and 200 cm-1, and a third 
one below 200 cm-1. Besides being characteristic of WO3 material, the three regions correspond to 
stretching, bending, and lattice modes, respectively. [7], [57] 
 
An electrochromic paper-based device as a diagnostic test for Cystic Fibrosis 
 
16 
 
Figure 10: Raman spectra of WN1, WN2, and WN3 samples. The spectra were collected with a 633 nm laser, at 
1% and 3 accumulations. 
Starting with sample WN1, the Raman spectrum obtained is typical of m-WO3. The two peaks with 
higher intensity, at wavenumbers of 806 and about 714 cm-1, correspond to the stretching vibrations of O-
W6+-O in octahedral WO6. At 607 cm-1 it is also observed a very weak peak, also related with stretching 
vibrations. Four weaker peaks at 323, 291, 273, and 241 cm-1 are assigned to the bending vibrations of 
W6+-O-W6+ bond of corner oxygen. Finally, the peak at 180 cm-1 is related to the lattice vibration. [7], [66] 
In WN2 spectrum, the peak at wavenumber 947 cm-1 corresponds to W6+=O bond and is related to 
the appearance of water between WO6 octahedra layers. This is a typical peak for all types of WO3 hydrates, 
proving that WN2 is also one. Water causes the distortion of WO6 octahedron and promotes kind of a 
broadening of the peak at 635 cm-1 which is related to the stretching vibration of W6+-O bond. Therefore, 
two peaks at 635 and 947 cm-1 identify the appearance of water in WO3 structure. At 809 and 676 cm-1, 
WN2 presents two peaks that are specific for the W6+-O-W6+ bond stretching vibrations. Finally, at around 
249 and 325 cm−1, the peaks from O–W6+–O bending mode appear, and the ones below 200 cm−1 (186 and 
161 cm−1) are related to the lattice vibration, as already seen. This Raman spectrum proves that WN2 is a 
sample of o-WO3∙0.33H2O. [66]–[68] 
In WN3 spectrum, the two peaks at 251 and 331 cm−1 are assigned to the bending vibrations of the 
W6+-O-W6+ bridging oxygen. According to the literature, well defined peaks centered at around 260, 320, 
650, 690, 786 and 810 cm-1 can be assigned to h-WO3 nanoparticles. However, the Raman spectrum of h-
WO3 nanowires is substantially different from that of the h-WO3 nanoparticles. In the case of nanowires, it 
can be observed an overlapping of bands in the region between 600 and 850 cm−1, and an exclusive 
terminal W=O stretching mode in the 925-965 cm−1 interval that is normally related to all types of WO3 
hydrates. These two facts can be observed in WN3 spectrum: two peaks centered at 742 and 802 cm−1, 
associated with the stretching vibration modes of O–W6+–O but with some overlap, and at 960 cm−1, related 
to terminal W=O stretching mode. Although this last peak could also be related with the presence of water 
as a result of a poor drying process, the XRD analysis of the sample contradicts it. [62], [68] 
The Raman spectroscopy data here presented supports the crystalline phases of each sample 
already established by XRD analysis, and confirms the high structural quality of WO3 NPs produced by 
MAHS. In conclusion, it can be noticed that the resulting crystallographic structure and morphology of WO3 
NPs is dependent on synthesis’ time, temperature, pH, and SDA. 
1.2. WO3 NPs by HS 
In addition to MAHS, HS was also used to produce WO3 NPs with o-WO3∙0.33H2O crystallographic 
structure, as already mentioned. For this sample, the production process did not undergo through an 
optimization. However, it was also characterized by XRD and SEM, and later tested on the devices. 
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 XRD analysis 
In Figure 11, it is presented the diffractogram obtained for the WO3 NPs sample produced by HS at 
180 ºC for 1 h. 
 
Figure 11: Diffractogram of WO3 NPs sample produced by HS at 180 ºC for 1 h. The diffractogram represented 
in black is the crystallographic file deposited in the ICDD data base with the reference #98-003-7822 for 
hydrated orthorhombic crystallographic structure of WO3. Peaks marked with ◊ are characteristic of 
H2WO4∙nH2O and peaks with ○ are non-identifiable.  
The diffraction peaks observed are attributed to o-WO3·0.33H2O with a mixture of a secondary 
product (○: 20.73º and 35.83º) not yet identified and H2WO4·nH2O (◊: 30.53º). These two additional peaks 
did not correspond to any file deposited in the ICDD data base and, basically, both are due to lattice 
distortions of the crystallographic structure during the slow growing of the NPs, as previously reported for 
WO3 NPs produced by the same method. [6], [51]  
 SEM analysis 
The SEM images of the sample produced by HS at 180 ºC for 1 h are presented in Figure 12. In this 
synthesis, it was not used an SDA and when this happens, the nanoparticles formed are of orthorhombic 
nature and aggregate to form a three-dimensional rectangular slab-like structure. [57] Analysing the 
images, the presence of two morphologies is very likely. One has bigger dimensions and a 
nanosheet/nanoplate structure while the other has smaller dimensions (around 15-25 nm), increasing the 
surface to volume ratio and providing more surface area for chemical and physical interactions. Comparing 
these results with the XRD analysis of this sample, the discrepancy of the NPs sizes can be associated 
with the presence of the intermediate product, H2WO4·nH2O.  
  
Figure 12: SEM images of the sample produced by HS at 180 ºC for 1 h, with different magnifications. 
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2. Devices’ production 
The devices obtained during the production process are presented in Figure 13.  
  
a) b) 
Figure 13: Devices obtained throughout the production process: a) after laser etching of ITO, and b) after 
deposition and curing of Ag ink. 
The devices were designed in a 2-electrode system architecture and were negatively patterned in a 
single PET/ITO sheet by laser, in a mask less approach. For the laser etching of ITO, the laser-cutting 
machine took around 18 s for a single device, which was followed by the 3-step cleaning process of the 
PET/ITO sheet.  
Before encapsulation, some devices were used to do preliminary tests described right after. 
2.1. Preliminary tests 
The first tests consisted in studying the deposition of the WO3 NPs dispersion on the devices by 
drop-casting. The best conditions found were dropping a 2 µL drop of the dispersion and letting it dry 
overnight. These conditions avoided the formation of the “coffee ring” effect and the late colouration of the 
WE centre, presented by drop-casting two drops (Figure 14 b)), and allowed a better uniformization of the 
deposited NPs, which did not happen when they were dried in a hot plate at 50 ºC for 6 min (Figure 14 c)). 
After deposition, all devices were protected from light with aluminium foil, once WO3 is also a photochromic 
material.  
The WO3 NPs dispersions were prepared by two methods: one was to grind and disperse the 
powders in a 1:1 mixture of EGBE and deionized water to achieve a concentration of 0.04 g/mL (Figure 14 
a)) – method 1 –, and the other was to disperse the powders obtained right after the washing process in 
the same mixture and concentration – method 2. The concentration used was equal to all of the four WO3 
NPs samples (WN1, WN2, WN3 and HS 180 ºC) to compare them later.  
In order to choose the best method, some devices were tested using a typical electrolyte used in 
electrochromic windows: LiClO4 1 M dissolved in PC. The electrolyte was drop-casted right on top of the 
WE and CE, followed by an appliance of -3 V (explained in the devices’ characterization) for 30 min, 
capturing the colour change of the NPs at 0, 5, 10, 20, and 30 min.  
a) Method 1  b) Deposition of two 2 µL drops c) Drying with hot plate 
     
    WN1 
 
          WN2 
 
      HS 180 ºC   
  
      HS 180 ºC 
 
   WN3 
  
       HS 180 ºC 
Figure 14: Observations during the preliminary tests of the devices before their encapsulation and after a 
colouration of 10 min. a) WO3 NPs dispersion produced by method 1; b) Deposition of two 2 µL drops of WO3 
NPs dispersion produced by method 2; c) Drying process using the hot plate of the WO3 NPs dispersion 
produced by method 2.  
All of the different WO3 NPs dispersions produced by method 2 presented the same behaviour as 
the ones represented in Figure 14 b) and c), that only served to exemplify. After several tests, it was obvious 
that the dispersions produced by method 1 were not adequate because the powder grounded was not so 
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fine, compromising the WO3 NPs dispersion and, consequently the colouration uniformity (Figure 14 a)). 
Thus, by using only the dispersions produced by method 2 and repeating the previous colouration tests, 
the WO3 crystallographic structure that presented the most intense colour, to use later in the final devices, 
was found. The tests were repeated at least three times for each sample, being one of them presented in 
Figure 15. 
 Time (min) 
Sample 0 5 10 20 30 
WN1 
     
WN2 
     
WN3 
     
HS 180 ºC 
     
Figure 15: Colouration tests of the four deposited WO3 NPs samples (c=0.04 g/mL) at an operating voltage of -
3 V during 30 min. 
Analysing Figure 15, it is possible to notice that every sample presented an electrochromic response 
visually detectable. This response is due to the formation of the tungsten bronze which presents a blue 
colouration. However, WN2 sample is the one that, for the same concentration of WO3 NPs, presents the 
most intense colour for the electrolyte used. This sample corresponds to o-WO3∙0.33H2O produced by 
MAHS, and according to the literature it is a more conductive material because of the presence of double 
bonds and hydroxyl terminal groups. Due to its higher electronic conductivity and increased structure 
hydration, an enhancement in lithium ion diffusion rate, and hence faster electrochemical response, is 
expected. Also, WN1 (m-WO3) can be excluded from further tests once its colour turns to a yellowish green 
and not in a uniform way, which can difficult the colour perception in the following tests. Besides, the 
electronic conductivity of stable WO3 NPs was reported to be the highest for o-WO3∙0.33H2O, as already 
mentioned, and gradually smaller for m-WO3 and h-WO3. [64], [69] 
As the first conclusions were reached, the next step was to develop an electrolyte based on NaCl in 
order to simulate the human sweat. The electrolyte developed had to be liquid and non-aqueous to avoid 
the influence of the H+ intercalation. Some solvents were studied (PC, and Acetonitrile) but for the NaCl 
concentrations used, only PG was able to dissolve the salt. 
The same colouration tests were repeated for the devices with the WN2, WN3 and HS 180 ºC NPs, 
using the new electrolyte (with a NaCl concentration of 60 mM), but this time with a colouration of only 6 
min, once this time was sufficient to stabilize the colour and is more suitable for a rapid test. The colour 
change of the NPs was captured at 0, 1, 2, 4, and 6 min, and no colouration was observed for WN2 and 
HS 180 ºC, as can be seen in Figure 16. For this reason, WN3 sample was the crystallographic structure 
chosen for the final devices. This fact is explained by the different size of the ions present in the two 
electrolytes, as well as the different openness degree of the studied WO3 geometries. The ionic radii of Li 
(145 pm) is smaller than the one of Na (180 pm), and although the difference is small (35 pm), it is sufficient 
to the non-occurrence of Na+ intercalation in the layered crystallographic structure of o-WO3∙0.33H2O. [70], 
[71] For the h-WO3 NPs, it was observed a colouration once its tunnel structure presents an openness 
degree higher than the structure of orthorhombic or monoclinic geometries. According to Sun et al., the 
theoretical intracrystalline tunnel size is 3.9 Å, which is more than sufficient to allow the intercalation of Na+, 
as well as other bigger cations to form tungsten bronzes. [51], [55] 
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 Sample (c=0.04 g/mL) 
Time (min) WN2 WN3 HS 180ºC 
6 
   
Figure 16: Colouration obtained at an operating voltage of -3 V during 6 min of the samples WN2, WN3 and HS 
180 ºC (c=0.04 g/mL) using the electrolyte composed by PG and NaCl at 60 mM. 
In order to promote a faster ion transport, PEO and PVP were added to the electrolyte 
aforementioned, forming a sodium complexed electrolyte. In section D of Appendices, it is described the 
production process of this electrolyte. Also, to improve the intensity of the h-WO3 NPs colouration, two other 
WO3 NPs concentrations were studied: 0.06 and 0.08 g/mL. The results of the colouration tests for these 
concentrations, using the new electrolyte with a NaCl concentration of 60 mM, are presented in Figure 17. 
 Time (min) 
[WO3 NPs] (g/mL) 0 1 2 4 6 
0.06 
     
0.08 
     
Figure 17: Colouration tests of the h-WO3 NPs (c=0.06 g/mL and c=0.08 g/mL) at an operating voltage of -3 V 
during 6 min, using the electrolyte composed by PEO, PVP, PG, and NaCl at 60 mM. 
Comparing these results with the ones obtained for WO3 NPs concentration of 0.04 g/mL, the 
intensity of the blue is stronger. This is explained by the higher concentration of NPs used, as well as the 
sodium complexed electrolyte which promoted a faster ion transport.  
As the best conditions related to the WO3 NPs production, concentration and deposition were found, 
the next step was the encapsulation of the devices. For the definition of the hydrophilic paper pads and the 
patterning plus cutting of the plastic pouches, the laser-cutting machine took 5 s and 4.3 s, respectively, for 
a single device. The appearance of the devices after the deposition of the WO3 NPs, as well as the final 
devices, is presented in Figure 18.  
  
a) b) 
Figure 18: Appearance of: a) the devices after the deposition of the WO3 NPs and before encapsulation; and b) 
the bottom and top view of the final devices. 
The dimensions of the individualized final devices (Figure 18 b)) were around 1.4 x 2.0 cm. After the 
encapsulation, all devices were stored, protected from the light, and characterized. Also, the best 
concentration of the WO3 NPs was then chosen. 
3. Devices’ characterization 
The first characterization of the devices was concerning the effectiveness of the ITO etching by the 
laser-cutting machine. To accomplish that, it was performed an EDS analysis on a device, after the 
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deposition of the WO3 NPs (c=0.06 g/mL) and before encapsulation. The device’s area of interest was one 
that englobed both WE and CE, and the etched PET/ITO separation gap. In Figure 19 it is presented the 
analysis obtained. 
    
a) b) c) d) 
Figure 19: SEM (a)) and EDS analysis (b), c), and d)) of the interface WE/etched PET/ITO area/ITO area/CE of a 
device with a WO3 NPs concentration of 0.06 g/mL, before encapsulation. 
The EDS analysis shows an effective ITO layer etching, once it is noticeable the absence of indium 
(In) and tin (Sn) on the etched areas between the electrodes. As such, laser method allows a fast, effective 
and high-resolution device patterning. Furthermore, it is a mask less method and allows freedom of design 
for the user. Confirmed the success of the devices production, a colourimetric analysis using the software 
ImageJ was carried out, before and after the devices’ encapsulation. 
3.1. Colourimetric analysis 
The colouration tests previously described (Figure 17) were implemented to the devices with the two 
best WO3 NPs concentrations (0.06 and 0.08 g/mL), during 6 min, using the electrolytes composed by PEO, 
PVP, PG, and all of the NaCl concentrations produced: 0, 30, 45, 60, 75, 90, and 120 mM. The goal was 
to find the concentration of NPs and the time that allowed a better distinction between the different NaCl 
concentrations.  
Due to the planar structure of the device, the use of paper, and also the ITO colouration interference, 
the devices were not optically characterized by UV-vis in the transmittance mode. Besides, in practical 
terms, it is simpler to record the colouration obtained on the device with a cell phone camera, for example, 
and analyse its colour using a specific software, than measuring its transmittance. As such, an RGB 
analysis using the software ImageJ was carried out. This analysis gives the relative intensity of each RGB 
channel, which varies between 0 and 255, being all 0 when the colour is black and 255 when the colour is 
white. In this work, the intensity of the WE blue colour is of interest and to evaluate it, the ratios between 
the arithmetic means of the intensities obtained for the blue and red channels (B/R) were recorded. Ratios 
higher than 1 are considered positive for the blue colouration and ratios lower than 1 are considered 
negative. For each condition, three devices were tested, and the first analysis was performed on the devices 
before encapsulation. The results of the RGB analysis are presented in Figure 20.  
  
          a)            b) 
Figure 20: Results obtained from the RGB analysis of the devices before encapsulation, for a concentration of 
WO3 NPS of: a) 0.06 g/mL; and b) 0.08 g/mL. 
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As expected, in both WO3 NPs concentrations, for a colouration time of 0 min and a NaCl 
concentration of 0 mM, the B/R values are below 1 which indicates that there was no blue colouration of 
the NPs. For the other four times and NaCl concentrations, the B/R values are above 1, indicating the blue 
colouration of the NPs. Furthermore, it is noticeable that the ratio values are higher for the higher 
concentration of WO3 NPs, 0.08 g/mL, which was also expected and visually seen.  
By analysing Figure 20, the only conditions that allow a proper distinction between different NaCl 
concentrations are a colouration time of 1 and 2 min for a WO3 NPs concentration of 0.06 g/mL and 1 min 
colouration for a WO3 NPs concentration of 0.08 g/mL. For these conditions, the B/R values increase with 
the NaCl concentration rise in the electrolyte. Although not so obvious, the rest of the conditions also show 
the same behaviour, proving the existence of a relation between the intercalation of Na+ in the h-WO3 
crystallographic structure and the intensity of the blue colouration presented by the NPs. This relation was 
already studied by De Matteis et al. [12], also in the development of a chromogenic device for CF diagnosis 
using a WO3 film deposited by electron beam on a commercial ITO/glass substrate. However, and besides 
the positive results of their work, the research group only used concentrations of NaCl dissolved in 
Acetonitrile anhydrous of 0, 30, 60, and 90, and 120 mM. 
To choose the best condition, the standard deviations had to be considered, and for a NPs 
concentration of 0.08 g/mL, in general, the values are higher. This can be explained by the ununiform NPs 
colouration for this concentration, due to the unnecessary number of NPs in the WE. The higher the 
concentration, the higher the time all NPs take to colouring, which translates into a ununiform colouration 
and an RGB analysis not so efficient nor reproductible. For these reasons, a WO3 NPs concentration of 
0.06 g/mL and a colouration time of 1 min was defined as the optimum condition for the CF diagnosis, 
presenting the following B/R values: 0.941±0.001 for 0 mM, 1.226±0.067 for 30 mM, 1.295±0.039 for 45 
mM, 1.368±0.033 for 60 mM, 1.400±0.018 for 75 mM, 1.453±0.034 for 90 mM, and 1.531±0.019 for 120 
mM. The only downside of this colouration time is related with the standard deviations’ overlap for NaCl 
concentrations of 30 and 45 mM, and also for 60 and 75 mM. However, these overlaps do not interfere with 
CF diagnosing, once non-affected individuals present a NaCl concentration in sweat lower than 30 mM, 
and CF patients present a NaCl concentration higher than 60 mM with an average of 80 mM. 
The same analysis was performed on the devices after encapsulation and with a WO3 NPs 
concentration of 0.06 g/mL, to compare with the previous results. For these devices, an electrolyte quantity 
of 60 µL, by excess, was drop-casted on the paper pads left outside each device. It took between 45 min 
and 1 h to cover all the area of the hydrophilic papers due to the viscosity of the electrolytes. The results of 
the analysis are presented in Figure 21. 
  
          a)       b) 
Figure 21: a) Results obtained from the RGB analysis of the devices after encapsulation, for a concentration 
of WO3 NPs of 0.06 g/mL; and b) Comparation between the B/R values obtained for the devices with a 
concentration of WO3 NPs of 0.06 g/mL before (1 min of colouration) and after (6 min of colouration) 
encapsulation, and respective calibration curves. Both images correspond to a device tested with the 
electrolyte containing 120 mM of NaCl before (left) and after (right) encapsulation. 
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After encapsulation, some previous features have remained. For a colouration time of 0 min and a 
NaCl concentration of 0 mM, the B/R values are below 1 (no NPs colouration) and for the rest, the values 
are above 1 (NPs colouration), as expected. Comparing these values with the previous obtained for the 
same WO3 NPs concentration before encapsulation, the B/R values are very similar, although not 
significantly lower (Figure 21 b)). This is explained by the presence of the hydrophilic paper in the device, 
which can interfere with the colouration of the NPs when there are contact issues. If the paper soaked in 
the electrolyte is not in contact with the NPs, the NPs will not colour or will, but taking more time. This also 
explains the best colouration time found, which is 6 min. As such, the optimum condition for the CF 
diagnosis using the devices after encapsulation is a colouration time of 6 min for a WO3 NPs concentration 
of 0.06 g/mL, presenting the following B/R values: 0.949±0.017 for 0 mM, 1.213±0.021 for 30 mM, 
1.281±0.018 for 45 mM, 1.345±0.022 for 60 mM, 1.390±0.049 for 75 mM, 1.466±0.034 for 90 mM, and 
1.530±0.039 for 120 mM. 
The results obtained and presented in Figure 20 and Figure 21, show that the developed devices 
can be used in the diagnosis of CF, after or before encapsulation with different optimum conditions. 
However, the human sweat presents other constituents beyond NaCl: K+, Mg2+, H+, bicarbonate (HCO3−), 
etc. As such, to test the selectivity of the devices, some additional tests were performed. 
 Selectivity tests 
Two more electrolytes were prepared, as described in section D of Appendices, with the maximum 
concentration of K+ and Mg2+ found in sweat, as reported in literature: 10 and 2 mM, respectively. [12] The 
previous colouration tests were repeated on the devices with a WO3 NPs concentration of 0.06 g/mL, before 
encapsulation, in order to test their selectivity. The images obtained during the colouration tests are 
presented in Figure 22.  
 Time (min) 
Tested cation 0 1 2 4 6 
K+ 
     
Mg2+ 
     
Figure 22: Colouration tests of the final devices, before encapsulation, with a WO3 NPs concentration of 0.06 
g/mL, at an operating voltage of -3 V during 6 min, using two electrolytes: one composed by PEO, PVP, PG, 
and KCl (10 mM), and other by PEO, PVP, PG, and MgO4S (2 mM). 
For each electrolyte, three devices were tested and all have shown colour intensities similar to the 
ones presented in Figure 22. As also observed by De Matteis et al. [12], the colouration obtained for the 
KCl electrolyte is more intense than the obtained for the MgO4S electrolyte, which is almost inexistent. This 
is explained by the difference between ion concentrations. For 1 min of colouration, the best time found for 
the devices before encapsulation, the blue intensity for KCl is considerable.  
With this in count, a third electrolyte composed by KCl, MgO4S, and NaCl at 0, 30, 60, and 120 mM, 
was prepared and also tested. An RGB analysis for this last electrolyte was performed. The goal was to 
study if the relation between the blue intensity of the NPs and the concentration of NaCl remained, as an 
electrolyte more similar to human sweat was approached. The results for a colouration time of 1 min are 
shown in Figure 23.  
As can be noticed, a relation between the blue intensity of the NPs and the concentration of NaCl 
remains, which proves the reliability of the device developed even with the influence of other ions as 
happens in human sweat. It is noteworthy that in this case, a B/R value higher than 1 is obtained for a NaCl 
concentration of 0 mM due to the contribution of the other ions present in the electrolyte. 
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Figure 23: Calibration curve obtained with the B/R values of the colouration tests (1 min) performed on the 
devices before encapsulation, with a concentration of WO3 NPs of 0.06 g/mL, and using the electrolyte 
composed by PEO, PVP, PG, NaCl, KCl, and MgO4S.  
As the functionality of the device was evidenced, the next stage was its electrochemical 
characterization. 
3.2. Electrochemical characterization 
The structural openness makes h-WO3 an interesting system to understand the structure-property 
relationship during electrochemical cycles, where charge transfer processes are usually involved. Although 
not presenting a practical contribution for the application here developed, the electrochemical response of 
the deposited h-WO3 NPs on the devices after and before encapsulation was evaluated by cyclic 
voltammetry, using the electrolyte composed by PEO, PVP, PG, and NaCl at 60 mM as the supporting 
electrolyte (Figure 24). The contact area between the electrolyte and the NPs was 0,785 cm2, and 10 cycles 
were performed from 3 to -3 V, as this was the applied potential during the previous tests, at a scan rate of 
100 mV/s for specific colouration/bleaching cycles. It is noteworthy that during each cycle, the colour of the 
NPs was observed to change from blue to a whitish-blue, reversibly. 
  
       a)          b) 
Figure 24: Cyclic voltammetry curves obtained for the devices a) before and b) after encapsulation. The 
measurement was performed using the electrolyte composed by PEO, PVP, PG, and NaCl at 60 mM, from 3 to 
-3 V at a scan rate of 100 mV/s, during 10 cycles. 
Comparing Figure 24 a) and b), the current density obtained for the device before encapsulation is 
higher than the obtained for the device after encapsulation. This fact can be related with the contact area 
between the electrolyte and the NPs, which is higher for the device before encapsulation once the 
electrolyte is drop-casted directly on the NPs, allowing its spread through all interstitial spaces between 
NPs. On the contrary, in the devices after encapsulation, the electrolyte is more concentrated on the NPs 
surface, as the paper pad is the vehicle for its propagation. Even if the same quantity of electrolyte is drop-
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casted on both devices, the amount that reaches the NPs will be different. Furthermore, when the contact 
area is bigger, it can be seen that the area between the curves also increases which is associated with 
more electro-reducible sites, thus experiencing higher charge insertion. These facts also explain the 
difference between the colouration tests’ time for both devices, being 1 min for the ones before 
encapsulation and 6 min for the ones after encapsulation.  
The developed devices were designed for a disposable colourimetric analysis with no need for a 
bleaching step. However, both colouring and bleaching steps were studied. As already mentioned, WO3 
exhibits a cathodic colouration which is connected to the insertion of both electrons and charge 
compensation ions for colouration (negative voltages) and the opposite mechanism for bleaching (positive 
voltages). As such, by analysing Figure 24, both reduction (colouration) and oxidation (bleaching) peaks 
can be observed. An interesting behavior can be observed for both Figure 24 a) and b). While the reduction 
peak remains almost equal throughout the 10 cycles, the one concerning the WO3 oxidation appear as two 
peaks that throughout the cycles merge into one at higher currents, stabilizing. Few research groups used 
NaCl-based electrolytes for WO3 applications, and the ones who used did not perform cyclic voltammetry  
analysis or used different production and deposition techniques [12], [55]. As such, several factors can be 
influencing the oxidation step of WO3. Sun et al. [55], studied the influence of the absorption of three 
different cations, Na+ included, on the stability of h-WO3 tunnels. The research group concluded that due 
to the larger size of this cation, compared to Li+ and H+, it induces a phase transformation in h-WO3. Also, 
they observed some changes in the electrochemical behavior of h-WO3 for the different electrolytes. With 
this in mind, structural deformations can be in fact happening, and the applied voltage can also be 
contributing for it. To test this assumption, similar additional tests were performed on the devices before 
encapsulation, by only changing the applied voltages to -2.5 V to 3 V and the number of cycles to 4. The 
results are presented in section F of Appendices. As can be seen in Figure 32 d), with the application of 
only -2.5 V, the cyclic voltammetry curves present a totally different behavior, presenting only one oxidation 
peak centered at around 0.3 V. As such, it is possible to conclude that when applying -3 V, the structure of 
h-WO3 can be somehow rearranged into other, altering the ions’ deintercalation process, stabilizing the 
rearrangement with the number of cycles. When only applying -2.5 V, this process does not occur. Other 
factor that can also be associated with the obtention of these peaks is the deterioration of the process’ 
reversibility. Some ions can be trapped in the crystallographic structure of h-WO3 and/or need higher 
voltages to leave the structure in the bleaching step, which can justify the shift observed in the oxidation 
voltages. When applying -2.5 V, the same does not happen, and the oxidation peak barely changes. Finally, 
the electrochromic behavior of ITO can also be interfering with the process. [72] However, to have certainty 
of these assumptions, additional tests need to be performed. 
With the number of cycles, it was observed that both coloured and bleached states were affected, 
fact that is associated mainly to trapped charges (Na+), unable to exit the material, and that can be observed 
in Figure 25 for the device before encapsulation. 
 
Figure 25: Charge insertion and extraction during consecutive 120 seconds colouration (-3 V) and bleaching 
(3 V) during the first cycle for the device before encapsulation. 
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Chronocoulometry is the measurement of charge per unit of time. As such, the experiment starts at 
a potential where no reaction is occurring and stepped instantaneously to a potential where either the 
oxidation or reduction occurs. As can be seen, inserted charges after 60 seconds of colouring do not equal 
the extracted charges after the bleaching step, presenting a charge balance less than 1 that is the optimum 
value for a durable material. Furthermore, the degradation of the electrolyte can also influence its ability to 
provide sodium ions for the electrochromic reactions to occur, once organic electrolytes are more 
susceptible to experience degradation. As such, this degradation can also affect the material colour 
stability. 
Cyclic voltammetry analysis was also performed at different scan rates (25, 50, 75, 100, and 125 
mV/s) between -3 and 3 V, for the device before encapsulation. The curves are shown in Figure 26. 
 
Figure 26: Cyclic voltammetry curves obtained for the device before encapsulation between -3 and 3 V at 
different scan rates: 25, 50, 75, 100, and 125 mV/s. The measurement was performed using the electrolyte 
composed by PEO, PVP, PG, and NaCl at 60 mM. 
As can be seen, the peak current, associated to the Na+ deintercalation, increases accordingly with 
the scan rate increasing, and also shifts towards the positive potential. For scan rates equal or higher than 
100 mV/s, the peak tends to stabilize. This reveals that the anodic peak current is linearly proportional to 
the square root of scan rate, which suggests a process that is diffusion controlled. [47], [73] Concerning the 
cathodic peak, it is more difficult to deduce due to its low prominence. 
The same behavior presented in Figure 24 can also be observed in Figure 26: the appearing of two 
peaks in the bleaching stage. However, for a scan rate of 125 mV/s these peaks are already merged. 
Comparing the first cycle at 100 mV/s (Figure 24) with the first cycle at 25 mV/s (Figure 26), these two 
peaks are more prominent at the lowest scan rate, as expected, once the analysis takes more time. Once 
more, similar additional tests were performed on the devices before encapsulation, by only changing the 
applied voltages to -2.5 V to 3 V and the number of cycles to 4 for each scan rate: 25, 50, 75, 100, and 125 
mV/s. The results are presented in section F of Appendices, and as already observed, for this potential 
range, the appearing of two peaks does not occur. 
3.3. Final device 
The CF diagnostic device here proposed was successfully developed. The disposable colourimetric 
WO3-based device represents a low-cost candidate for POC diagnostic applications, especially in resource-
limited environments, once it was produced with cost-effective and simpler methods: MAHS for the WO3 
NPs production, and laser technique for ITO etching of the PET/ITO sheet. While MAHS provides a total 
control over the shape and size of the NPs with a low temperature process, the laser technique offers a 
fast and high-resolution device patterning allied to a freedom of design for the user. 
It is noteworthy that this device is based on sweat Na+ concentrations measurement. Compared to 
other devices that measure NaCl concentrations, the one here proposed is more accurate since it has 
higher selectivity for Na+ due to this cation intercalation on the crystallographic structure of h-WO3. Although 
Na+ concentration in sweat is elevated in CF patients, the current CFF guidelines recognize that its 
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determination is less discriminatory when compared to Cl-. [15] However, multiple studies identify the 
reliability of using Na+ for CF detection, and even recommend the use of both to avoid diagnostic errors. 
[12], [74], [75] Nevertheless, Cl- or Na+ values greater than 60 mmol/L are consistent with the diagnosis of 
CF. [76] 
In Figure 27 is presented the final apparatus needed for the use of the device in the diagnosis of CF. 
  
a) b) 
Figure 27: Final apparatus needed for the use of the device in the diagnosis of CF: a) a 3 V battery connected 
to the device and a cell phone for recording the colouration presented by the device after usage; b) calibration 
curve obtained with the B/R values of the devices after encapsulation with a WO3 NPs concentration of 0.06 
g/mL and a colouration time of 6 min using the electrolyte composed by PEO, PVP, PG and NaCl. The dashed 
lines represent the B/R values correspondent to the NaCl concentration of 30 and 60 mM, that indicate a 
negative and positive diagnosis for CF, respectively. 
As already mentioned, this device can be used in two different stages, both with different advantages: 
before or after encapsulation. For both options, Wescor Macroduct® sweat collection system can be used, 
which includes sweat stimulation by pilocarpine iontophoresis for 5 min, and sweat collection in a plastic 
coil placed over the iontophoretically-stimulated area on the skin. [15] If the user chooses to use the 
developed device before encapsulation, the collected sweat can be drop-casted directly on the WE. If not, 
by using the device after encapsulation, the collected sweat can also be drop-casted on the paper pad, 
waiting till it covers the WE (between 45-60 min for 60 µL of the electrolyte tested), or the device can be 
placed directly over the iontophoretically-stimulated area on the skin, using a medical dressing to attach it 
on the skin. This way, the stimulated sweat goes directly to the paper pad. This is the main advantage of 
the proposed device compared to other electrochromic devices: instead of having a typical electrochromic 
device structure with an electrolyte layer, the electrolyte is drop-casted on the WE only on time of usage, 
which eliminates leakage problems. 
After the drop-casting of the electrolyte, an operational voltage of -3 V is applied to the device during 
1 or 6 min if using the device before or after encapsulation, respectively. This voltage can be provided using 
a power supply as the one used in this work, a 3 V battery as represented in Figure 27 a), or even using 
the power from the cell phone. The colour intensity obtained is then recorded with a cell phone camera for 
further RGB analysis using a proper software. Depending on the option chosen, the B/R values 
correspondent to a negative and a positive diagnosis for CF are different. In Figure 27 b), the calibration 
curve represented corresponds to the B/R values obtained for the device after encapsulation, with a 
colouration time of 6 min using the electrolyte composed by PEO, PVP, PG, and NaCl. For this case, a 
negative result for CF is found for B/R values smaller than 1.213±0.021 (30 mM of NaCl) and a positive 
result for B/R values equal or higher than 1.345±0.022 (60 mM of NaCl). In case of using the device before 
encapsulation, a positive diagnosis is obtained for B/R values equal or higher than 1.368±0.033 (60 mM of 
NaCl) and a negative diagnosis for B/R values smaller than 1.226±0.067 (30 mM of NaCl). If the B/R value 
obtained is between these two limits, in the intermediate range, the examined person must perform 
additional tests to better evaluate its condition.  
The developed device was tested using different NaCl-based electrolytes that deviate from the real 
constitution of human sweat. Although a more complex electrolyte was tested during the selectivity tests, 
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with very satisfactory results, human sweat presents several more constituents, including water. De Matteis 
et al. [12] opted to evaporate the human sweat sample to avoid the intercalation of H+. The same can be 
applied to this device: the water can be evaporated and the remaining salt can be dissolved in the 
developed solvent (PEO, PVP and PG), proceeding with the rest of the process. 
As already mentioned, an early diagnosis of CF facilitates early implementation of therapy, which 
can significantly improve the prognosis and life quality of the affected patients. However, according to a 
survey undertook by the European Cystic Fibrosis Society back in 2017, in Europe, the cost of a sweat test 
can vary between 20-300 €. [4] In contrast, and as discriminated in Table 4, the device here developed has 
a cost of only 13 cents (0.128 €). This analysis does not include the costs related with the electricity of the 
equipment used (microwave, oven, laser machine, centrifuge, desiccator, ultrasonic bath and hot plate). 
Table 4: Costs analysis of the developed device. 
Material Quantity Cost Cost/device (€) 
PET/ITO sheet 30.5 cm × 30.5 cm × 127 µm 29 €/sheet 8.63×10-2  
Laminating pouches 9.9 cm × 6.7 cm × 125 µm 0.12 €/pouch 4×10-2 
Paper Whatman n.º4 46 cm × 57 cm × 205 µm 2.18 €/sheet 1.15×10-3 
h-WO3 NPs 0.12 mg  8.03×10-3 €/mg 9.64×10-4 
  Total: 0.128 € 
  
 
An electrochromic paper-based device as a diagnostic test for Cystic Fibrosis 
 
29 
Chapter IV: Conclusions and Future Perspectives 
The aim of this work was the development of an electrochromic POC device, based on WO3 NPs, 
for a facile diagnosis of CF especially in resource-limited environments. The synthesis of the NPs was 
performed by HS and MAHS. The ones produced by MAHS went through an optimization process that 
consisted in the variation of microwave programme, synthesis’ temperature, pressure, power, and time, to 
achieve three crystallographic structures: m-WO3 (WN1); o-WO3∙0.33H2O (WN2); and h-WO3 (WN3).  
The optimization process of the WO3 NPs synthesis through MAHS was successful, being the last 
programme tested (Dynamic 180 ºC for 1 h with a maximum power of 200 W) the one with the best 
conditions to reach the desired crystallographic structures, analysed by XRD analysis, and also greater 
yields, especially for WN3. The “Dynamic” programme allowed a better control of temperature and time 
during synthesis, leading to the achievement of products with no impurities. In order to complement this 
study, and also to improve the crystallographic structure of all samples, especially WN3 and its yield, a 
temperature of 200 ºC during 40 min, for example, could be tested.  
Raman spectroscopy proved to be an excellent auxiliary technique to XRD analysis since it confirmed 
the crystalline phases of the samples after the optimization process. SEM analysis allowed to study the 
morphology of all samples and also to analyse the dimensions of the NPs obtained. For WN1 sample, 
rectangular nanoplates were obtained with a medium length of 107 ± 47.7 nm. For WN2, nanosheets were 
obtained (medium length of 826 ± 258 nm) and for WN3 nanowires with a medium length of 350 ± 122 nm. 
Throughout this analysis, it was possible to notice that the resulting crystallographic structure and 
morphology of the WO3 NPs produced are dependent on synthesis’ time, temperature, pH, and SDA. The 
same precursor (Na2WO4∙2H2O) was used in all samples, being the WN3 sample’s SDA (Na2SO4) different 
from WN1 and WN2 samples’ SDA (NaCl). For WN3, the sulphate ions acted as capping agents by covering 
some crystal facets of the initial WO3 crystal nuclei, promoting a faster growth rate along c-axis. When 
chloride ions are used it is believed that a similar process occurs. However, the growth of the initial WO3 
crystal nuclei is favored in a different specific direction, as observed in the data. [51], [62] 
In conclusion, it was evidenced that MAHS is a method capable to produce NPs with high structural 
quality with a lower power consumption and faster reaction times. 
Concerning the sample produced through HS at a temperature of 180 ºC during 1 h, all XRD peaks 
were identified as characteristic of o-WO3∙0.33H2O except for three additional peaks. One was related to 
the presence of H2WO4∙nH2O in the sample, while the other two were already reported as characteristic of 
lattice distortions in the crystallographic structure of WO3 NPs while being formed. Through the analysis of 
its SEM image, this sample seemed to present two types of NPs, probably associated with the presence of 
H2WO4∙nH2O: one with bigger dimensions and a nanosheet/nanoplate structure, and the other with smaller 
dimensions (around 15-25 nm). It is noteworthy that this sample did not go through any optimization 
process, so as a future perspective it could be done. 
After the NPs’ synthesis, the fabrication of the devices and the realization of some preliminary tests 
took place. As mentioned, a CO2 laser technology was used in the devices’ production, which saved time 
and costs. It only took 27.3 s for the production of each device (ITO etching, cutting the hydrophilic paper 
pads and patterning plus cutting of the plastic pouches), which presented a final dimension of around 1.4 x 
2.0 cm. In the preliminary tests it was found that a 2 μL drop of the NPs’ dispersion followed by a natural 
drying overnight were the best conditions to produce the devices. The drop-casting step was of great 
importance to obtain a good uniformization of the deposited NPs, as well as a later uniform colouration. In 
fact, as a future perspective, screen printing technique could also be tested to find the one that allows the 
best NPs’ uniformization.  
For the colouration tests, an electrolyte based on PEO, PVP, PG, and NaCl at different 
concentrations (0, 30, 45, 60, 75, 90, and 120 mM) was developed to simulate the human sweat. The tests 
were performed on the devices during 30 min at an operating voltage of -3 V, and WN3 was the only sample 
that showed a colouration, fact explained by the tunnel structure of h-WO3 that allowed the intercalation of 
Na+. As such, WN3 was the WO3 crystallographic structure chosen for the final devices, with a dispersion 
concentration of 0.06 and 0.08 g/mL.  
The next step was the proof of concept with the diagnosis of CF and, for that, colouration tests were 
performed during 6 min at -3 V on the devices with the two above mentioned NPs concentrations, before 
the devices’ encapsulation. Due to their planar structure, the use of paper, and also the ITO colouration 
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interference, the devices were not optically characterized by UV-vis in the transmittance mode. Instead, the 
comparison between the blue colouration intensities was analysed by an RGB analysis, using ImageJ 
software, and the ratio of the average intensities in blue and red channels was calculated. The devices with 
a WO3 NPs concentration of 0.06 g/mL allowed the best distinction between the different NaCl 
concentrations, for a colouration time of 1 min, compared to the concentration of 0.08 g/mL. The B/R values 
obtained for each NaCl concentration were: 0.941±0.001 for 0 mM, 1.226±0.067 for 30 mM, 1.295±0.039 
for 45 mM, 1.368±0.033 for 60 mM, 1.400±0.017 for 75 mM, 1.453±0.034 for 90 mM, and 1.531±0.019 for 
120 mM. After encapsulation, the best time of colouration was 6 min. However, the B/R values obtained 
were smaller due to the presence of the paper pad, which can interfere with the colouration of the NPs 
when there are contact issues. The B/R values obtained were: 0.949±0.017 for 0 mM, 1.213±0.021 for 30 
mM, 1.281±0.018 for 45 mM, 1.345±0.022 for 60 mM, 1.390±0.049 for 75 mM, 1.466±0.034 for 90 mM, and 
1.530±0.039 for 120 mM. 
Selectivity tests were also performed to study the influence of common interferents in sweat (Mg2+ 
and K+) in the colouration of the devices. It was obtained a colouration for both, but the one obtained for 
the KCl electrolyte was more intense than for the MgO4S electrolyte, fact explained by the difference 
between ion concentrations. However, a relation between the blue intensity of the NPs and the 
concentration of NaCl remained, which proved the reliability of the device developed even with the influence 
of other ions. 
Although the devices here developed were designed for a disposable colourimetric analysis, an 
electrochemical characterization was performed by cyclic voltammetry and chronocoulometry. Both 
reduction and oxidation peaks were observed and an interesting behaviour concerning the bleaching step 
occurred. While the reduction peak remained almost equal throughout 10 cycles, at a scan rate of 100 
mV/s, the one concerning the WO3 oxidation appeared as two peaks that throughout the cycles merged 
into one at higher currents, stabilizing. Several factors can be influencing the oxidation step of WO3 like the 
electrochromic behaviour of ITO, the deterioration of the process’ reversibility, and the applied voltage (-3 
V) that can be inducing a phase transformation in the h-WO3, as already reported elsewhere. [55] However, 
additional tests need to be implemented to have certainty of these assumptions, like an XRD analysis 
before and after the colouration step of the devices.  
Some studies are still needed to characterize the electrolytes produced. XRD analysis could be used 
to investigate the semi-crystalline nature of the PEO/PVP blend, the influence of NaCl addition on the 
polymer blend crystallinity, and also to confirm the dissolution of the salts. FTIR analysis could confirm the 
complexation of the salt used with the polymer host, and could also indicate if there was a good miscibility 
between PEO and PVP. The electrical conduction mechanism in the blend could also be studied to 
complete the characterization. [46] Furthermore, different solvents could be studied and tested in order to 
reduce the viscosity of the electrolyte developed here. This way, it would be possible to reduce the time 
that the electrolyte takes to cover the paper pad of the devices after encapsulation. Also, electrolytes with 
a composition more similar to human sweat or even real human sweat could be tested. The B/R values 
obtained could then be compared with the results from a more precise and CFF accepted technique, as 
coulometry. In addition, durability tests could be performed to study the stability of the devices throughout 
the time, for both before and after encapsulation. Related with the devices after encapsulation, a study 
concerning the use of different types of paper could also be done, in order to study the influence of the 
paper pad porosity in the NPs colouration or just in the time that the electrolyte takes to completely cover 
it.  
Concluding, the goal of this work was achieved with the development of a WO3-based POC device 
that represents a reliable low-cost candidate for CF diagnosis (13 cents, not including costs related with 
the electricity of the equipment used) especially in resource-limited environments. Furthermore, some of 
the results here presented were published in a poster format at two conferences: the 32nd Edition of the 
Eurosensors Conference in Graz, Austria (9-12th September 2018); and the 6th Dresden Nanoscale 
Symposium in Dresden, Germany (31st August 2018). Both posters are presented in section G of 
Appendices. 
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Appendices 
A. CFTR protein 
As illustrated in Figure 28, CFTR protein has five domains: two nucleotide-binding domains (NBDs), 
capable of binding and hydrolysing ATP; two membrane-spanning domains (MSDs) each composed of six 
subunits, which form the channel pore; and one regulatory domain (R), a group of amino acids. The channel 
opens when its R domain is phosphorylated by protein kinase A and when ATP is bound at the NBDs. [3], 
[11], [77] 
 
Figure 28: CFTR protein structure: a) Linear structure; b) 3D structure in the cell membrane. [3] 
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B. WO3 crystallographic structures: monoclinic, orthorhombic and hexagonal 
As already mentioned, WO6 units undergo some changes in the position of the central W atoms, 
promoting several crystalline modifications to WO3. Three of them are described right after. 
The structure of stable monoclinic WO3 is a ReO3-type structure with corner-sharing WO6 octahedra 
connected in the a-, b- and c-directions, as already described and as depicted in Figure 29. This leads to 
the formation of a stacked layer structure. [52], [55] 
In the orthorhombic WO3∙0.33H2O structure, an infinite plane of WO6 octahedra share their corners 
and form six-membered rings along the (001) plane, as shown in Figure 29. Each (001) plane contains two 
types of WO6 octahedra. Type I consists of a WO6 octahedron connecting six different octahedra by corner-
sharing. The four oxygen atoms along the plane (001) are shared by four neighbouring octahedra in the 
same layer, while the other two, that are perpendicular to the (001) plane, are shared with the adjacent 
layers above and below. This ensures the connection between the layers and thus the stability of this 
structure. Type II octahedra, WO5(H2O), consist of four oxygen atoms in the (001) plane, and the two that 
are off the (001) plane are substituted by a short terminal W=O bond and a longer W–H2O bond. Contrary 
to Type I, the two oxygen atoms off the (001) plane do not bond to other W atoms of adjacent layers above 
and below. As a result, an infinite layer is formed by corner-sharing the two octahedra types in the (001) 
plane. [78] Such an arrangement results in strong interactions within layers, and relatively weaker 
interactions between adjacent layers, resulting in a less compact structure that beneficiates the ion 
intercalation/deintercalation during the electrochromic process. [5] 
The hexagonal WO3 structure is built up of slightly distorted WO6 octahedra arranged in six-
membered rings by sharing corner oxygens along the (001) plane. This leads to the formation of large 
hexagonal shaped tunnels throughout the entire unit cell, which also allows a better ion 
intercalation/deintercalation during the electrochromic process. [55], [78] 
 
 
 
Monoclinic WO3 Orthorhombic WO3 Hexagonal WO3 
Figure 29: Crystallographic structures of WO3: monoclinic, orthorhombic, and hexagonal. Adapted from [78].  
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C.  Materials 
Table 5: List of all used reagents and respective chemical formula, purity, CAS, and company. 
Reagent 
Chemical 
formula 
Purity CAS Company 
Ethanol C2H5OH 96% 64-17-5 
Carlo Erba 
Reagents (Dasit 
Group) 
Ethylene glycol butyl ether 
(EGBE) 
C6H14O2 ≥ 99% 111-76-2 Sigma-Aldrich 
Hydrochloric acid HCl 37% 7647-01-0 Fisher Chemical 
Lithium perchlorate LiClO4 ≥ 98% 7791-03-9 Sigma-Aldrich 
Magnesium sulphate 
anhydrous 
MgO4S ≥ 98% 7487-88-9 Fluka 
PE-AG-530 Flexible Silver 
(Ag) Conductive Ink* 
- - - 
Conductive 
Compounds 
ITO coated PET # 
(30.5 cm × 30.5 cm × 127 µm) 
In2O3/SnO2 - - Sigma-Aldrich 
Polyethylene oxide (PEO) 
Mv~100 000 
(-CH2CH2O-)n - 25322-68-3 
Aldrich 
Chemicals 
Polyvinylpyrrolidone (PVP) 
MW~1 300 000 
(C6H9NO)n - 9003-39-8 
Aldrich 
Chemicals 
Potassium chloride (crystals) KCl - 7447-40-7 
José M. Vaz 
Pereira, S.A. 
Propylene carbonate (PC) C4H6O3 99.5% 108-32-7 Acros Organics 
Propylene glycol (PG) C3H8O2 - 57-55-6 LabChem 
Sodium chloride NaCl 99.5% 7647-14-5 Panreac 
Sodium sulphate anhydrous Na2SO4 99% 7757-82-6 Panreac 
Sodium tungstate dihydrate Na2WO4∙2H2O ≥ 99% 10213-10-2 
AnalaR 
NORMAPUR® 
(VWR Chemicals) 
 
*Surface resistivity: < 0.025 Ω/sq/mil 
#Surface resistivity: 60 Ω/sq 
 
An electrochromic paper-based device as a diagnostic test for Cystic Fibrosis 
 
38 
D. NaCl-based electrolytes’ preparation 
By adjusting the experimental procedure described elsewhere, a viscous liquid non-aqueous NaCl-
based electrolyte was produced to test the devices. [46] PG was used as solvent, and the quantities of 
each reagent were adapted. The best procedure found is described below.  
1. Add 6.5 g of PEO to 100 mL of PG and stir for 12 h at 600 rpm and 35 ºC; 
2. Add 2.17 g of PVP to the mixture, maintaining the same conditions for 12 h; 
3. Pour the mixture into 7 flasks and add NaCl in order to make seven different concentrations with 
a final volume of 10 mL: 0, 30, 45, 60, 75, 90, and 120 mM; 
4. Stir, maintaining the same conditions, over one night. The electrolyte obtained for a 60 mM 
concentration of NaCl is presented in Figure 30 a). 
To study the influence of Mg2+ and K+ in the WO3 NPs colouration, two more electrolytes were 
produced: one with KCl (10 mM) and other with MgO4S (2 mM). The concentrations used were as described 
and tested elsewhere. [12] For each electrolyte, the PEO+PVP+PG mixture already prepared was poured 
into a flask with a final volume of 5 mL, followed by the addition of the respective reagent and a stirring step 
at 600 rpm and 35 ºC, over one night. 
A fourth electrolyte was produced and it consisted in joining all reagents to make a mixture with 4 
different NaCl concentrations: 0, 30, 60, and 120 mM. For each electrolyte, the PEO+PVP+PG mixture 
already prepared was poured into a flask with a final volume of 5 mL, followed by the addition of KCl (10 
mM), MgO4S (2 mM), and the respective amount of NaCl, with a final stirring step at 600 rpm and 35 ºC, 
over one night. 
  
a) b) 
Figure 30: a) Final aspect of the electrolyte produced with PG, PEO, PVP, and a 60 mM concentration of NaCl. 
b) Formation of the polymer blend between PEO and PVP. The blend occurs through a hydrogen bond between 
the carbonyl group of PVP and the methylene group of PEO. [79] 
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E. XRD analysis 
In order to facilitate the perception of the optimization process using MAHS, all XRD analysis data 
presented was arranged in a different way. 
a) WN1 b) WN2 
  
c) WN3 
 
Figure 31: Resume of the synthesis’ optimization process using MAHS for sample a) WN1, b) WN2, and c) WN3. 
The diffractograms represented in black are the crystallographic files deposited in the ICDD data base with the 
references #98-007-1506, #98-003-7822, and #98-001-3851, for monoclinic, hydrated orthorhombic, and 
hexagonal crystallographic structures of WO3, respectively. Peaks marked with ◊ and ♦ are characteristic of 
H2WO4∙nH2O and m-WO3 crystallographic structures, respectively. 
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F. Cyclic voltammetry 
Additional cyclic voltammetry analysis performed on the devices before encapsulation. The curves 
were obtained using the electrolyte composed by PEO, PVP, PG, and NaCl at 60 mM, from 3 to -2.5 V at 
different scan rates (25, 50, 75, 100, and 125 mV/s) during 4 cycles each. 
  
       a)         b) 
  
      c)         d) 
 
      e) 
Figure 32: Cyclic voltammetry curves obtained for the devices before encapsulation. Measurements were 
performed using the electrolyte composed by PEO, PVP, PG, and NaCl at 60 mM, from 3 to -2.5 V during 4 
cycles, at a scan rate of a) 25 mV/s, b) 50 mV/s, c) 75 mV/s, d) 100 mV/s, and e) 125 mV/s. 
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